bims-camemi Biomed News
on Mitochondrial metabolism in cancer
Issue of 2026–07–05
53 papers selected by
Christian Frezza, Universität zu Köln



  1. Nature. 2026 Jul 01.
      Patients with colorectal cancer (CRC) frequently develop liver metastases1-3. The prognosis of these patients is skewed by the histopathological heterogeneity of their liver metastases4,5. Patients with 'replacement' metastases have a 5-year overall survival of less than 44.2%, compared with 73.4% in patients with 'encapsulated' (previously known as desmoplastic) metastases5; yet there are currently no approved therapies targeting replacement liver metastases. Here we show that treatment-naive patients with CRC with liver steatosis have an increased occurrence of replacement metastases compared with patients without steatosis. Mechanistically, we find that steatosis-promoted fatty acid oxidation increases formation of replacement metastases by increasing MYC stability through acetylation. In turn, MYC activates proline synthesis, fuelling collagen production, enabling growth of replacement metastases. Targeting MYC, P5CS or COL1A1 suppresses the occurrence and growth of replacement metastases in patient-derived organoids, mouse or patient-derived xenograft models. Spatial metabolite and protein analyses of liver metastases from patients with CRC further support this mechanism. In conclusion, we provide a mechanistic understanding of the emergence of liver metastases with poor prognosis in treatment-naive patients with CRC, identifying potential targets for therapeutic intervention.
    DOI:  https://doi.org/10.1038/s41586-026-10686-2
  2. Science. 2026 Jul 02. 393(6806): 90-97
      Sickness behaviors are common in cancer-associated cachexia and affect up to half of lung cancer patients. We demonstrate that among the most common cancer mutations, loss of liver kinase B1 (Lkb1) promotes the development of cachexia in preclinical models of lung cancer. In an effort to improve caloric intake with an obesogenic high-fat diet, we paradoxically observed worsened cachexia-associated sickness. We found that local production of prostaglandin E2 (PGE2), rather than circulating factors, promotes sickness and that genetic, dietary, and pharmacological inhibition of tumor-derived PGE2 suppresses sickness and cachexia. Notably, we demonstrate that lung sensory neuron abrogation prevents PGE2-dependent cachexia. Our study establishes localized tumor-derived signals to sensory neurons, rather than circulating factors, as drivers of cachexia and highlights a previously unknown role of the peripheral nervous system in cancer cachexia.
    DOI:  https://doi.org/10.1126/science.adz4196
  3. Sci Adv. 2026 Jul 03. 12(27): eaee5417
      Oncocytic (Hürthle cell) carcinoma of the thyroid (OCT) is characterized by widespread loss of heterozygosity (LOH), mitochondrial accumulation, and recurrent mitochondrial DNA mutations leading to impairment of complex I. Here, we establish and characterize a novel OCT cell line, UT946, which displays severe mitochondrial electron transport chain dysfunction and a Warburg metabolic phenotype. Using a series of cytoplasmic hybrids, we establish that the complex I defect in UT946 stems from a nuclear-encoded loss-of-function mutation in the complex I subunit NDUFS1. To our surprise, the mutation in NDUFS1 was inherited as a recessive germline allele that underwent LOH in the tumor to expose functional loss of complex I. A reanalysis of 91 OCT tumor genomes revealed that LOH-driven exposure of recessive germline mutations in complex I subunits was a recurrent mechanism underlying complex I inactivation in OCT. These findings unveil a previously unidentified germline-driven mechanism of complex I loss and metabolic reprogramming in cancer and provide further evidence of the selective pressure for complex I impairment in OCT.
    DOI:  https://doi.org/10.1126/sciadv.aee5417
  4. Nat Metab. 2026 Jul 03.
      Post-translational modifications (PTMs) dynamically regulate protein function, with metabolite-driven PTMs linking metabolism to protein regulation1,2. We have previously discovered lysine lactylation, showing that lactate can directly modify proteins and influence cancer progression3,4. Recently, pyruvate, another glycolytic metabolite, was shown to directly modify STAT1 at lysine 201, thereby suppressing type I interferon signalling5. Yet, the enzyme governing this modification, its substrate landscape and potential roles beyond innate immunity remain entirely unexplored. Here we report the systematic characterization of lysine pyruvylation (Kpy). Through biochemical and proteomic approaches, we establish the widespread existence of this modification, identifying 88 Kpy sites in mammalian cells. We investigate the dynamic regulation of Kpy upon metabolic perturbations and find that Kpy fluctuates with changes in glycolytic flux and pyruvate levels. Furthermore, we identify sirtuin 3 (SIRT3) as responsible for removing Kpy, while histone acetyltransferase 1 (HAT1) and p300 (EP300) catalyse its addition. Finally, we explore the function of Kpy in transcriptional regulation. Overall, Kpy expands the repertoire of metabolite-driven PTMs and provides insights into how pyruvate directly modulates protein function.
    DOI:  https://doi.org/10.1038/s42255-026-01556-2
  5. Cell Chem Biol. 2026 Jun 30. pii: S2451-9456(26)00194-7. [Epub ahead of print]
      Mitochondrial lipid peroxidation is a major component of oxidative damage and is also thought to contribute to ferroptosis. Lipid peroxidation is generally assessed from the accumulation of oxidized end products, such as 4-hydroxynonenal (HNE). However, these report on damage throughout the cell and are affected by changes in how oxidized phospholipids are turned over. To overcome these constraints, we developed MitoLiPOX, a mitochondria-targeted mass spectrometry probe. Mitochondria targeting and detection sensitivity were achieved by incorporating a lipophilic triphenylphosphonium cation. Responsiveness to lipid peroxidation was brought about by building in a bis-allylic carbon-hydrogen bond mimic that, upon oxidation and processing, generated a single product, MitoLiPOX-OH. LC-MS/MS quantification of MitoLiPOX-OH followed by normalization to the amount of MitoLiPOX present enabled ratiometric quantification of mitochondrial lipid peroxidation. We then used MitoLiPOX to assess mitochondrial lipid peroxidation during ferroptosis in vitro and in zebrafish in vivo.
    Keywords:  exomarker; lipid peroxidation, ferroptosis; mitochondria; oxidative stress
    DOI:  https://doi.org/10.1016/j.chembiol.2026.05.015
  6. Nat Commun. 2026 Jul 01.
      Mitochondria remain at the core of cell metabolism, whereas the nucleus integrates cellular and environmental signals to activate genes. However, the mechanisms that directly link cellular metabolism to gene regulation are not well understood. Here we show, a metabolic pathway in the nucleus controls acetylation of histones by nuclear localization of mitochondrial enzymes aconitase (ACO2) and isocitrate dehydrogenase (IDH2). Metabolic tracing studies show that IDH2 and ACO2 catalyze reductive carboxylation of α-ketoglutarate to rapidly synthesize citrate to increase nuclear acetyl-CoA pool. Genetic and proteomic analyses reveal nuclear IDH2 and ACO2 form a complex with KAT2A/GCN5 for acetylation of histones to increase chromatin accessibility and activation of proliferative genes. Robust nuclear expressions of ACO2 and IDH2 drive aggressive tumors indicating the tumorigenic potential of IDH2-ACO2-KAT2A axis. Altogether, our work reveals a paradigm coupling a nuclear metabolic pathway with histone acetylation to control of gene expression that accentuates hyperproliferative phenotype in tumors.
    DOI:  https://doi.org/10.1038/s41467-026-74786-3
  7. Am J Physiol Cell Physiol. 2026 Jul 02.
      Mitochondrial calcium (Ca2+) transport is a central regulator of cellular metabolism, linking bioenergetics, signaling, and organelle function. While its role in controlling oxidative phosphorylation and cell fate is well established, emerging evidence indicates that mitochondrial 2+ handling is also tightly connected to amino acid metabolism and nitrogen balance. In this review, we integrate classical and recent findings to examine how mitochondrial 2+ transporters, including the mitochondrial calcium uniporter complex (MCUc), Na+/2+ exchangers, and H+/Ca2+ exchange systems, respond to nutritional cues and contribute to metabolic adaptation. We discuss how variations in amino acid availability and dietary protein intake may modulate the expression and activity of Ca2+ transport machinery, and explore the emerging role of mitochondrial proteases in regulating transporter turnover and activity, highlighting unexplored questions and future prospects in the field. We discuss how mitochondrial Ca2+ fluxes influence amino acid-sensitive processes including autophagy, mitochondrial morphology, and substrate utilization, while also potentially modulating the urea cycle through effects on key enzymes and metabolite transporters. Overall, we find that mitochondrial Ca2+ transport is a dynamic interface between nutrient availability and metabolic regulation, with implications for physiology and metabolic disease, but significant gaps remain regarding specific mechanisms within the integration of Ca2+ signaling with amino acid-sensing pathways.
    Keywords:  amino acid metabolism; mTORC1; mitochondrial calcium; mitochondrial proteases; urea cycle
    DOI:  https://doi.org/10.1152/ajpcell.00212.2026
  8. Nat Med. 2026 Jul 03.
      Aging profoundly remodels the immune system, impairing defense, repair and homeostatic function across tissues. Because the immune system operates in every organ, its deterioration has been proposed to drive or exacerbate systemic dysfunction and accelerate overall biological aging, making it an attractive biomarker and target for geroscience-guided trials. Despite this central role, there is no consensus on how to quantify immune aging, especially in clinical trials. Here, we establish a translational framework to identify immune aging biomarkers for this purpose. We define five evaluation criteria for immune aging biomarkers and apply these to candidate biomarkers, discussing their utility in the context of a major international healthspan competition, XPRIZE Healthspan. Metrics encapsulating multidimensional aspects of immune function, inflammaging scores and functional assays performed best against our selection criteria. Finally, we identify promising emerging measures, together with critical gaps that must be addressed to develop reliable, predictive biomarkers of human immune competence. Our framework provides a coherent path toward actionable and clinically meaningful immune aging biomarkers capable of quantifying immune fitness and resilience, and accelerating the clinical translation of geroscience-guided interventions.
    DOI:  https://doi.org/10.1038/s41591-026-04493-5
  9. bioRxiv. 2026 Jun 28. pii: 2026.06.25.733848. [Epub ahead of print]
      Mitochondrial Ca2+ uptake through the mitochondrial calcium uniporter complex (MCUcx) is a critical determinant of cellular metabolism, integrating Ca2+ signaling with ATP production and redox control. Yet how MCUcx activity is constrained to prevent Ca2+ overload and cell injury, and how the essential MCU regulator (EMRE), a subunit required for channel activity, mechanistically supports MCUcx function remains incompletely defined. Here, using a newly developed high-sensitivity assay to quantify MCUcx function in intact mitochondria, we uncover two fundamental roles of EMRE. First, EMRE is required for robust matrix Ca2+-dependent inhibition of MCUcx, acting through a juxtamembrane site via a mechanism distinct from MICU1-mediated inhibition at low cytosolic Ca2+. Second, by decoupling channel function from regulation, we demonstrate that EMRE promotes robust ion permeation through MCUcx, elevating its role from a structural scaffold to an active determinant of channel throughput. Together, our findings refine current models of mitochondrial Ca2+ regulation, establish EMRE as an essential multifunctional regulator of uniporter activity, and highlight the utility of our assay for probing MCUcx biophysical mechanisms and enabling the discovery of uniporter modulators.
    DOI:  https://doi.org/10.64898/2026.06.25.733848
  10. Nat Metab. 2026 Jun 29.
      Mitochondria play central roles in cellular metabolism and in key processes such as inflammation, stress response, cell death and signalling. Mitochondrial quality control (MQC) mechanisms continuously monitor organelle integrity and function, and repair or eliminate damaged mitochondria to replace them with newly formed, healthy organelles. MQC is particularly important under metabolic or environmental stress conditions. Failure of MQC paves the way to chronic diseases, such as diabetes, metabolic syndromes and immunosenescence. This Review summarizes our current understanding of MQC biology in the context of healthy human longevity. We explore the regulation of MQC in physiological conditions and explain how the dysregulation of MQC in ageing negatively impacts systemic metabolism and immune function. We discuss emerging therapeutic strategies-such as NAD+, AMPK activators and caloric restriction-that maintain a robust MQC to improve metabolic resilience and illustrate how preclinical and clinical studies can leverage MQC as a potential gerotherapeutic target.
    DOI:  https://doi.org/10.1038/s42255-026-01563-3
  11. J Gen Physiol. 2026 Sep 07. pii: e202613979. [Epub ahead of print]158(5):
      Along with the membrane potential and respiration, mitochondrial matrix volume is a critical parameter that determines mitochondrial function. Mitochondria undergo constant changes in matrix volume and crista dynamics, and in processes that are critical for normal metabolic rates and pathophysiological responses. Changes in matrix volume cannot be easily measured by conventional fluorescence imaging techniques due to the size of the suborganellar structures, which are below resolution. This challenge was successfully resolved in studies of isolated mitochondria with the use of scattered light. Here, we use dark-field imaging, which relies on scattered light contrast, to measure matrix volume dynamics in living cells. We demonstrate that mitochondrial volume changes can be easily detected as changes in intensity of the scattered light following matrix volume modulation with K+ ionophores or by onset of the permeability transition. Specifically, we found that stimulation of K+ influx leads to an increase in mitochondrial matrix volume, while stimulation of K+ efflux leads to matrix shrinkage, and that activation of the permeability transition leads to high-amplitude mitochondrial swelling in wild-type but not in cells lacking subunit c of ATP synthase. These results directly demonstrate the dynamic nature of mitochondrial matrix volume and its link to physiological and pathological ion transport.
    DOI:  https://doi.org/10.1085/jgp.202613979
  12. Sci Adv. 2026 Jul 03. 12(27): eaef4971
      Magnesium (Mg2+) is the most abundant divalent cation in cells, yet the mechanisms mediating its organellar transport remain poorly defined. We identify endoplasmic reticulum (ER) Mg2+ adenosine triphosphatase (ATPase) (ERMA) as the transporter that drives Mg2+ uptake into the ER lumen, establishing the ER as a bi-ionic intracellular reservoir. MagFRET biosensors targeted to the ER demonstrate that ERMA mediates dynamic ER Mg2+ storage and robust adenosine 5'-triphosphate-dependent Mg2+ uptake reaching 15 to 30 millimolar. Cryo-electron microscopy structures of human and mouse ERMA reveal a P-type ATPase fold with an unwound transmembrane 4 (TM4) that coordinates Mg2+ via the unique PILP backbone and the TM5 residue Q1110, whose mutation markedly impairs ERMA-mediated Mg2+ uptake. Functional reconstitution of domain mutants, ERMA-SERCA chimeras, and pathogenic variants confirm ERMA as an ER-resident Mg2+ pump and gatekeeper of ER Mg2+ ionic equilibrium.
    DOI:  https://doi.org/10.1126/sciadv.aef4971
  13. Biochem Soc Trans. 2026 Jul 29. 54(7): 887-899
      Organelle contact sites are highly dynamic and specialized regions where distinct organelles come into proximity, enabling direct inter-organelle communication. These structures play fundamental roles in cellular homeostasis by coordinating the exchange of lipids, metabolites, and ions, as well as regulating key processes such as organelle dynamics, mitochondrial fission, autophagy, and metabolic integration. Alterations in contact site architecture and function have been increasingly associated with a wide range of human diseases, including neurodegeneration, metabolic disorders, and cancer. Despite their biological relevance, the nanoscale nature and dynamic behaviour of contact sites have historically posed significant challenges for their accurate detection and functional characterization. Here, we provide a comprehensive overview of the methodologies currently available to study organelle contact sites, ranging from classical approaches such as electron microscopy and biochemical fractionation to advanced imaging techniques and genetically encoded reporters. We discuss recent developments in high-resolution and live-cell microscopy that have improved the spatial and temporal resolution of contact site analysis, as well as emerging tools designed to selectively label, quantify, and manipulate these interfaces. Attention is given to the next generation of engineered reporters capable of sensing molecular and ionic exchanges at contact sites, thereby moving beyond structural description toward functional interrogation. By critically evaluating the strengths and limitations of existing approaches, we aim to provide a framework for selecting appropriate tools and to highlight future directions in the field. Ultimately, advancing our ability to monitor and dissect organelle contact sites will be essential for understanding their contribution to cellular physiology and disease.
    Keywords:  Organelle contact sites; SPLICS; genetically encoded reporters
    DOI:  https://doi.org/10.1042/BST20250371
  14. Res Sq. 2026 Jun 25. pii: rs.3.rs-10046174. [Epub ahead of print]
      A general puzzle in stem-cell and ageing biology is why a few cellular clones come to dominate an ageing tissue while otherwise similar neighbours do not, a fate that the average transcriptional state of a cell predicts poorly. Here we ask whether the variability between sister cells of a clone, rather than their transcriptional state, is the property that predicts ageing-associated clonal selection, using the haematopoietic stem cell (HSC) as a tractable test case. We combine heritable lineage tracing with single-cell RNA sequencing across heterochronic and homochronic transplantation models to link early transcriptional states of individual HSC clones to their long-term functional output in vivo. To quantify transcriptional heterogeneity at clonal resolution, we developed a computational framework (scCloneVar) that estimates mean-adjusted gene expression variance and identifies differentially variable genes (DVG). We found that ageing increases transcriptional heterogeneity at both the cellular and clonal levels, reflected by elevated variability in gene expression programs that regulate stem cell activity. We observe polyclonal expansion of HSC independently of the age of the host or the donor mice; however, individual clones in heterochronic transplantations show reduced self-renewal and fitness compared to sister clones in homochronic transplantations, indicating better adaptation of HSC clones in age-matched microenvironments. Strikingly, transcriptional features measured prior to transplantation predict clonal self-renewal at later time points, with transcriptional variability, captured by DVG, providing predictive power beyond that captured by mean expression differences. DVG-associated programs are conserved across mouse and human HSC, are established by middle age, and are enriched in pathways relevant to clonal haematopoiesis and myeloid malignancy risk. Together, our findings support a model in which ageing expands transcriptional heterogeneity that tracks with subsequent clonal selection, rendering clonal fate partially predictable from early cellular states.
    DOI:  https://doi.org/10.21203/rs.3.rs-10046174/v1
  15. Cell Rep. 2026 Jul 02. pii: S2211-1247(26)00707-2. [Epub ahead of print]45(7): 117629
      In many cancers, stably elevated MYC levels drive sustained activation of anabolic programs and the cell cycle, creating opportunities for the synthetic-lethal targeting of MYChigh tumors. Enhanced mitochondrial respiration is a hallmark of MYC overexpressing cancer cells. Mitochondrial respiration sustains the TCA cycle by regenerating NAD+ through complex I-mediated oxidation of NADH, supporting the anabolic demand of MYC-driven cells. Metabolic carbon tracing reveals that MYC shifts the TCA cycle carbon source from glucose to glutamine. Inhibition of the glutamine-fueled TCA cycle using NAD+-depleting complex I inhibitors promotes MYC-dependent synthetic lethality in breast cancer cells. In mouse models of MYChigh tumors, combined inhibition of complex I and glutaminolysis produces persistent suppression of tumor growth. Altogether, the elevated respiration of MYChigh cells supports a glutamine carbon-enriched TCA cycle that meets anabolic demand, rendering MYChigh tumors selectively vulnerable to mitochondrial respiration and glutaminolysis inhibitors.
    Keywords:  CP: cancer; CP: metabolism; MYC; TCA cycle; breast cancer; cancer; complex I; glutamine; metabolism; mitochondria; mitochondrial respiration
    DOI:  https://doi.org/10.1016/j.celrep.2026.117629
  16. Biochemistry. 2026 Jun 29.
      Lactate has undergone a major conceptual shift, from a glycolytic waste product to a circulating metabolic currency and, more recently, a multifunctional regulator of physiology. It serves as a mitochondrial fuel, an epigenetic modifier via protein lactylation, a ligand for the G-protein-coupled receptor HCAR1, and a precursor for endocrine-like N-lactoyl amino acids. This convergence raises a central question: how can a single metabolite support such distinct roles without functional conflict? We propose that the resolution lies not in lactate concentration alone but in two complementary organizing principles: subcellular routing and chemical form. Transporter localization, enzyme compartmentalization, donor formation, and metabolic competition bias lactate toward distinct biochemical fates, while conversion into chemically distinct intermediates─including lactyl-CoA, lactoyl-glutathione, d-lactate, and N-lactoyl amino acids─further constrains the biological outcomes that lactate can support. Lactate's fate is influenced by the cellular compartments it accesses, a process constrained by specific monocarboxylate transporters at the plasma and mitochondrial membranes, isoform-specific localization of lactate dehydrogenases, and compartmentalized enzymatic machinery that converts lactate into distinct biochemical donors. Mitochondrial oxidation, protein lactylation, extracellular signaling, and N-lactoyl amino acid synthesis should therefore not be viewed as parallel consequences of elevated lactate concentration. Instead, they represent interconnected metabolic fates that draw from shared lactate pools and are influenced by compartmental access and local enzymatic context. Here, we integrate evidence from metabolism, epigenetics, and signaling into a spatial framework in which lactate function depends on where it is routed. In this view, lactate is not a promiscuous metabolite but a compartmentalized intermediate whose biological effects are shaped by spatial context. We further distinguish between established, emerging, and speculative aspects of this compartmentalized view to highlight key gaps and prioritize future experimental testing.
    DOI:  https://doi.org/10.1021/acs.biochem.6c00251
  17. EMBO J. 2026 Jul 03.
      Adrenergic stimulation of brown adipocytes induces a robust detachment of mitochondria from lipid droplets (LD), which is followed by lipolysis and lipid catabolism. However, the signals inducing mitochondria attachment or detachment, and their role in lipid metabolism, remain unknown. Here, we reconstituted mitochondria-LD interaction in brown adipocyte tissue (BAT) ex vivo. We find that removal of mitochondria from lipid droplets permits higher lipolytic activity of recombinant lipases. Testing the effect of thermogenic secondary messengers and metabolites on attachment and detachment identified elevated mitochondrial matrix calcium as a potent inducer of detachment. Further, deletion of the mitochondrial sodium/calcium exchanger, NCLX, resulted in reduced attachment and increased detachment, while activation of NCLX increased attachment. We find that elevated matrix calcium causes detachment by inducing architectural transformation of peridroplet mitochondria (PDM) from their typical LD-surface-bound crescent shape into a round shape. PDE2A inhibition activates NCLX and increases PDM content in BAT in vitro and in vivo. We conclude that a surge in mitochondrial matrix calcium ions serves as a potent signal to induce mitochondrial detachment from lipid droplets, thereby facilitating lipolysis.
    DOI:  https://doi.org/10.1038/s44318-026-00827-8
  18. Proc Natl Acad Sci U S A. 2026 Jul 07. 123(27): e2609132123
      Lysosomes maintain cellular homeostasis by degrading proteins delivered via endocytosis and autophagy and by recycling building blocks for organelle biogenesis. Lysosomal storage disorders (LSDs) comprise a group of diseases affecting diverse lysosomal functions. To facilitate molecular phenotyping across diverse LSD gene classes, we are developing a library of human embryonic stem cells engineered to lack individual LSD genes as a resource for the field. Here, we report our initial stem cell toolkit lacking one of 23 LSD genes, including the majority of genes associated with sphingolipidoses and neuronal ceroid lipofuscinoses, and its use in the generation of a proteomic resource for induced cortical-like and midbrain dopaminergic-like neurons. In-depth abundance and correlation profiling across organelles and suborganelle components revealed potential vulnerabilities that reflect distinct patterns of proteome alterations across both genotypes and neuronal cell types. We characterize alterations in the mitochondrial proteome associated with GBA1 and ASAH1 deficiency and identify synaptic and mitochondrial defects in ASAH1-/- induced neurons that correlate with defects in neuronal firing rates. Moreover, we developed an informatic pipeline for proteome-wide identification of individual protein-protein interactions and protein complexes that may be disrupted as a result of LSD gene deficiency. Finally, we visualized structural alterations of ASAH1-deficient endolysosomes in situ using cryoelectron tomography, revealing swollen organelles that were largely devoid of dense internal membranes characteristic of wild-type cells, but containing numerous intralumenal vesicle compartments. This toolkit and associated proteomic landscapes provide a resource for defining molecular signatures associated with LSD gene dysfunction and organelle vulnerability.
    Keywords:  iNeurons; lysosome; organelle; protein interactions; proteomics
    DOI:  https://doi.org/10.1073/pnas.2609132123
  19. Science. 2026 Jul 02. 393(6806): eaea5113
      Local fibroblast development and densities influence organ health and disease, although it remains unclear how tissue fibroblast topography is controlled in situ. Here, we defined Group 2 innate lymphoid cells (ILC2s) as key regulators of fibroblast homeostasis in the pancreas. ILC2s colocalized with fibroblasts expressing the genes Pi16+Dpp4+Ly6c+ in an interstitial niche of the exocrine pancreas, which encapsulates the organ parenchyma. ILC2s specifically regulated the expansion of Pi16+Dpp4+Ly6c+ fibroblasts, which have progenitor capacity, while restraining differentiated intraparenchymal Col15a1+ fibroblasts during inflammation. These circuits reinforced fibroblast numbers after injury and set an inflammatory threshold. The ILC2 and Pi16+Dpp4+Ly6c+ fibroblast progenitor niche expanded around tumors and controlled cancer-associated fibroblast ontogeny and density. Hence, ILC2-fibroblast dialogue represents a regulatory node that locally orchestrates tissue homeostasis and pathology.
    DOI:  https://doi.org/10.1126/science.aea5113
  20. Res Sq. 2026 Jun 22. pii: rs.3.rs-9986029. [Epub ahead of print]
      Macrophage metabolic remodeling sustains inflammatory responses to pathogens. At homeostasis, macrophages rely on oxidative phosphorylation (OXPHOS), but during inflammation, OXPHOS is downregulated and aerobic glycolysis increases. Increased flux through the tricarboxylic acid (TCA) cycle increases the availability of substrates, such as succinate, that promote pro-inflammatory transcription. While metabolic remodeling has been extensively characterized, the mechanisms governing the shift from OXPHOS to glycolysis remain unclear. We recently identified a single nucleotide variant (SNV) in a mitochondrial protein, coenzyme Q6 (COQ6), that accelerates OXPHOS downregulation during infection with the Gram-positive organism Streptococcus pneumoniae . Because the SNV converts an aspartate residue (D) to tyrosine (Y), we denote the variant as COQ6 DY . Here, we now systematically compare the inflammatory responses of macrophages expressing Coq6 DY or Coq6 WT after stimulation with the S. pneumoniae -derived pneumolysin (PLY), or with lipopolysaccaharide (LPS; a toxin derived from Gram-negative bacteria). We found that Coq6 DY reprograms macrophage mitochondrial metabolism by changing the balance between OXPHOS and glycolytic activity and relative TCA metabolite concentrations at homeostasis. Furthermore, responses to PLY varied by host genotype and by concentration of available glucose, whereas responses to LPS were less dependent upon genotype. We therefore identify a non-canonical function of COQ6 in governing mitochondrial metabolism.
    DOI:  https://doi.org/10.21203/rs.3.rs-9986029/v1
  21. Mol Cell. 2026 Jul 02. pii: S1097-2765(26)00384-9. [Epub ahead of print]86(13): 2446-2448
      In this issue, Ahsan et al.1 reveal that de novo lipogenesis averts biguanide-induced reductive stress by consuming reduced nicotinamide adenine dinucleotide phosphate, reframing fatty acid synthesis as a conserved redox safety valve that determines whether biguanide-driven metabolic stress remains adaptive or turns lethal.
    DOI:  https://doi.org/10.1016/j.molcel.2026.06.013
  22. Am J Physiol Cell Physiol. 2026 Jun 29.
      As has been known for many decades, oxaloacetate (OAA) is a very potent inhibitor of succinate dehydrogenase (SDH). However, the phenomenon has received little attention for several reasons to be discussed. Although the interaction between OAA and the structure of SDH has been scrutinized, there has been little attention to the mechanism underlying OAA inhibition of SDH in respiring mitochondria or to its functional implications. In recent years, we have used more advanced methodology to examine these issues. OAA is unstable and therefore very difficult to detect by mass spectroscopy. Hence, we used a novel NMR approach to assess OAA in mitochondria of muscle, brown adipose tissue, and liver under active respiratory conditions. We also used a modification of existing technology to assess mitochondrial respiration in states apart from the extremes of state 4 and state 3. We found strong evidence that mitochondrial OAA content and inhibition of SDH is dependent on inner mitochondrial membrane potential (ΔΨ) and the effects of ΔΨ on the NADH/NADM+ redox state. Further, we examined the effects of perturbed OAA content by deleting glutamic-oxaloacetic transaminase (GOT2) which metabolizes OAA and glutamate to aspartate and α-ketoglutarate. Such deletion enhanced mitochondrial OAA and impaired metabolism through SDH. Here we review historical and recent studies addressing OAA inhibition of SDH. We also discuss the possible physiological role of OAA/SDH interaction and whole-body consequences. Further, we describe novel methodology for detection of OAA and assessment of mitochondrial function under conditions of clamped mitochondrial inner membrane potential.
    Keywords:  Mitochondria; glutamic-oxaloacetic transaminase-2; mitochondrial inner membrane potential; oxaloacetate; succinate dehydrogenase
    DOI:  https://doi.org/10.1152/ajpcell.00200.2026
  23. Bioessays. 2026 Jun;48(6): e70157
      For decades, eukaryotic circadian timing has been framed mainly through nuclear transcription-translation feedback loops (TTFLs). Here, we synthesize evidence supporting a broader organelle-centered model in which cellular time emerges from dynamic coupling between TTFL clocks, post-translational feedback loop (PTFL) oscillators, and entrained rhythmic modules across mitochondria, endoplasmic reticulum, lysosomes, peroxisomes, Golgi apparatus, plasma membrane, and cytoskeleton. Metabolic flux, redox cycling, proteostasis, ion handling, membrane excitability, trafficking, and mechanotransduction act as temporal currencies that either sustain selected transcription-independent rhythms or transmit phase information within a TTFL-coordinated network. In this layered architecture, the TTFL remains a central integrator that stabilizes inter-organelle phase relationships, aligns intracellular rhythms with environmental Zeitgebers, and links biochemical state to epigenetic and RNA-based regulation. We propose that circadian dysfunction reflects progressive intracellular desynchronization rather than isolated clock-gene failure, opening diagnostic and therapeutic opportunities aimed at restoring subcellular temporal coherence.
    Keywords:  biology; cell biology; circadian rhythm; cytoskeleton; endoplasmic reticulum; epigenetics; mechanotransduction; neuroscience; proteostasis
    DOI:  https://doi.org/10.1002/bies.70157
  24. Nat Commun. 2026 Jul 02. pii: 5788. [Epub ahead of print]17(1):
      Metabolic enzymes perform life-sustaining functions in various cellular compartments. Anecdotally, metabolic activity is observed to vary between genetically identical cells, which impacts drug resistance, differentiation, and immune cell activation. However, no large-scale resource systematically reporting metabolic cellular heterogeneity exists. Here, we leverage imaging-based single-cell spatial proteomics to reveal the extent of non-genetic variability of the human enzymatic proteome, as a proxy for metabolic states. Nearly two fifths of enzymes exhibit cell-to-cell variable expression, and half localize to multiple cellular compartments. Metabolic heterogeneity arises largely autonomously of cell cycling, and individual cells reestablish these myriad metabolic phenotypes over several cell divisions. We reveal through multiplexed imaging that metabolic states are continuous and that the correlation between metabolic pathways is metabolic state dependent. These results establish cell-to-cell enzymatic heterogeneity as an organizing principle of cell biology that may rewire our understanding of drug resistance, treatment design, and other aspects of medicine.
    DOI:  https://doi.org/10.1038/s41467-026-74172-z
  25. Curr Opin Cell Biol. 2026 Jun 29. pii: S0955-0674(26)00057-8. [Epub ahead of print]101 102669
      Cell migration is a fundamental biological process essential for development, tissue repair, and cancer metastasis. While cytoskeletal dynamics, adhesion turnover, and biochemical signalling are known regulators of migration, intracellular organelles have traditionally been regarded as passive components. Emerging evidence now reveals that organelles actively reorganize and polarize during migration, undergoing spatial and functional specialization to coordinate force generation, adhesion dynamics, metabolic support, and mechanochemical signalling. In this review, we discuss recent advances highlighting how endo-lysosomes, the endoplasmic reticulum (ER), mitochondria, the Golgi apparatus, and migrasomes regulate cell migration. We synthesize emerging principles, identify common mechanistic themes, and outline key open questions that will guide future investigations into how organelles govern cell motility across physiological and pathological contexts.
    DOI:  https://doi.org/10.1016/j.ceb.2026.102669
  26. Cell Death Discov. 2026 Jun 27.
      Cancer-associated genetic, epigenetic, and microenvironmental factors impose shortages of tryptophan and arginine, which induce specific codon reassignments (substitutants) in their proteomes. Whether cancers are deprived of other amino acids is unknown. Histidine is an essential amino acid reported to be low in certain tumor types. Therefore, we investigated the potential for a histidine shortage in cancer. Using cultured cancer cells, we pinpointed histidine to glutamine (H>Q) substitutants as the most pronounced proteomic event following histidine deprivation. We then scanned cancer proteomes for H>Q proteins and observed a marked enrichment in pancreatic, uterine, and kidney cancers. Mechanistically, we propose that H>Q is a result of tRNA misalignment, and used tRNA glutamine (tRNA(Gln)) modifications at the wobble position to demonstrate it. We further show that URM1-mediated U34 thiolation boosts H>Q production and influences the survival of cancer cells following histidine deprivation, suggesting a potential role for H>Q. Additional characterization of H>Q substitutants revealed preferred sequences and the maintenance of H>Q host protein expression despite the absence of histidine, indicating cellular regulation and functional consequences. Thus, histidine shortage induces H>Q substitutants, a regulated mistranslation event that pinpoints histidine limitation in cancer and impacts cell survival.
    DOI:  https://doi.org/10.1038/s41420-026-03225-5
  27. Nat Chem Biol. 2026 Jun 29.
      The ternary complex, composed of eIF2, GTP and initiator methionyl-tRNA, delivers the first amino acid to the ribosome to initiate protein synthesis. Eukaryotic initiation factor 2B (eIF2B) catalyzes GDP to GTP exchange on eIF2, thereby setting the ternary complex level. Stress-induced phosphorylation converts eIF2 from the substrate of eIF2B into an inhibitor (eIF2-P). This conversion reduces ternary complex levels and induces the integrated stress response (ISR). Here we chart an allosteric axis running through eIF2B, revealing the importance of an α-helix in its β-subunit, the 'latch-helix', that hooks onto the α-subunit to induce eIF2B activity. eIF2-P binding promotes latch-helix unhooking, opening eIF2B, which inhibits its activity. Convergently evolved viral proteins stabilize this latch-helix-binding active state of eIF2B. Using these insights, we generated ISR-activating compounds that stabilize eIF2B in its inhibited, unlatched state. Our study thus highlights how long-range eIF2B allostery can be pharmacologically manipulated to sustain or attenuate the ISR.
    DOI:  https://doi.org/10.1038/s41589-026-02256-4
  28. bioRxiv. 2026 Jun 23. pii: 2026.06.22.733842. [Epub ahead of print]
      The gut microbiome produces numerous metabolites that influence mammalian health. While microbiome composition and diet influence metabolite concentrations, how these factors interact remains incompletely defined. Here we find production of imidazole propionate (ImP), a microbial metabolite associated with cardiometabolic and neurodegenerative diseases, is determined by the balance of competing metabolic pathways that catabolize histidine to ImP or short-chain fatty acids (SCFAs). We show glutamate serves as a preferred substrate that selectively inhibits histidine conversion to SCFAs, redirecting flux to increased ImP production across mouse- and human-derived microbial communities. We find dietary monosodium glutamate (MSG) acting via this mechanism boosts ImP production in the mouse gut, transiently impairing glucose tolerance and increasing systemic ImP. These findings show that predictable interactions between dietary substrate and microbial competition control systemic ImP levels, providing a mechanistic framework for understanding microbiome metabolite production more broadly.
    DOI:  https://doi.org/10.64898/2026.06.22.733842
  29. Nat Commun. 2026 Jun 30.
      Genetic heterogeneity contributes to the variable therapeutic responses in cancers. Frequent SPOP mutations and recurrent CHD1 deletions define distinct molecular subtypes of prostate cancer (PCa) with differential responses to anti-androgen therapy. Ferroptosis, an iron-dependent cell death mechanism driven by lipid peroxidation, has emerged as a promising anticancer strategy. Here, we identify SPOP mutations and CHD1 deletion as key genetic determinants of ferroptosis susceptibility in PCa. Using genetically engineered human and murine models, we show that SPOP mutations enhance, whereas CHD1 deletion impairs, the efficacy of ferroptosis inducers targeting GPX4. Mechanistically, SPOP and CHD1 exert opposing effects on ferroptosis by antagonistically regulating the MYC-ACSL4 axis. Furthermore, we demonstrate that targeting cholesterol metabolism with cholesterol-lowering agents restores ACSL4 expression and re-sensitizes SPOP/CHD1 co-deficient tumors to ferroptosis-inducing therapy. Our findings establish SPOP/CHD1 as upstream genetic regulators of ferroptosis and provide biomarker-driven combinatorial strategies to enhance ferroptosis-based therapy in men with advanced PCa.
    DOI:  https://doi.org/10.1038/s41467-026-75010-y
  30. Sci Adv. 2026 Jul 03. 12(27): eaed6463
      Cysteine metabolism plays a crucial role in the growth and survival of non-small cell lung cancer (NSCLC), although the mechanisms governing its regulation are not fully understood. Here, we demonstrate that the RNA demethylase FTO is a therapeutic target that drives cysteine metabolism in NSCLC cells. Genetic or pharmacologic inhibition of FTO reduced cystine uptake and transsulfuration activity, leading to depleted intracellular glutathione, elevated reactive oxygen species (ROS), and ROS-mediated DNA damage and cell death. Mechanistically, FTO promotes the expression of the cystine uptake transporter SLC7A11 and the transsulfuration enzymes cystathionine β-synthase (CBS) and cystathionine γ-lyase (CTH) to promote NSCLC cystine uptake, transsulfuration activity, and survival. FTO inhibition increased lipid peroxidation, reduced tumor growth, and resulted in additive therapeutic benefit in combination with radiotherapy in multiple NSCLC xenograft models. Collectively, our study reveals a role for FTO in cysteine metabolism and highlights the therapeutic potential of targeting cancer epitranscriptomics and cysteine metabolism for NSCLC therapy.
    DOI:  https://doi.org/10.1126/sciadv.aed6463
  31. Nat Commun. 2026 Jun 30. pii: 5552. [Epub ahead of print]17(1):
      Life on Earth has evolved in a form suitable for the gravitational force. Although the pivotal role of gravity in gene expression has been suggested, the molecular details remain unclear. Here, we show that mitochondria utilize gravity to activate protein synthesis within the organelle. Genome-wide ribosome profiling reveals reduced mitochondrial translation in mammalian cells and Caenorhabditis elegans under microgravity. We found that attenuation of cell adhesion through laminin-integrin interactions caused the phenotype. Mitochondrial translation is activated by a signal relayed by FAK, RAC1, PAK1, BAD, and Bcl-2 family proteins in the cytosol, and the mitochondrial fatty acid synthesis (mtFAS) pathway in the matrix. Consumption of mitochondrial malonyl-CoA by mtFAS reduces the malonylation of the translational machinery and accelerates the rates of translational initiation and elongation. Physiologically, this system operates in mechano-response of skeletal muscles. Our work provides mechanistic insights into how cells convert gravitational and mechanical forces into translation in mitochondria.
    DOI:  https://doi.org/10.1038/s41467-026-74493-z
  32. Commun Biol. 2026 Jul 02.
      Tumor cells must occupy and thrive in a competitive microenvironment marked by limited metabolites, including essential amino acids like methionine. Using a leukemia suppression model and CRISPR screening, we found that the choline transporter SLC44A1 is overexpressed in leukemia patients and impacts leukemogenesis. Choline is an important nutrient for membrane synthesis and less commonly contributes to the methionine cycle. A metabolic analysis demonstrated that metabolites of the methionine pathway are significantly elevated in leukemic cells. Surprisingly, dietary restriction of methionine accelerated leukemogenesis in vivo. Choline can serve as an alternative source for methionine via the enzymatic activity of CHDH and BHMT. Under restrictive methionine conditions, BHMT and CHDH are significantly upregulated. In vivo, BHMT and CHDH are necessary for leukemia progression where they utilize choline as an alternative source to satisfy increased methionine demand. This pathway represents a vulnerability in cancer cells that may be exploited for therapeutic intervention.
    DOI:  https://doi.org/10.1038/s42003-026-10598-x
  33. Trends Cell Biol. 2026 Jun 29. pii: S0962-8924(26)00102-9. [Epub ahead of print]
      Intercellular mitochondria transfer has emerged as a new form of cell-to-cell communication with profound consequences for cellular fate. A growing body of evidence defines mitochondria transfer between cells as a new pathological program in which cancer cells appropriate functional mitochondria from donor cells, thereby co-opting conserved physiological mechanisms of energy allocation to gain bioenergetic and phenotypic advantages. Our recent work demonstrates the prevalence of mitochondria transfer at the nerve-cancer interface, with neurons, though not exclusively, serving as a prominent source of the organelle. This suggests an unrecognized role of the nervous system in systemic energy redistribution and indicates that tumors may exploit this ancient, physiologically grounded mechanism to fuel progression and metastasis.
    Keywords:  cancer neurometabolism; kleptoplasmy; mitochondria transfer
    DOI:  https://doi.org/10.1016/j.tcb.2026.06.003
  34. J Biochem. 2026 Jul 01. pii: mvag050. [Epub ahead of print]
      Methylation of DNA, histones, and RNA is central to the regulation of circadian rhythms, yet the biochemical origin of the methyl groups driving these modifications has received comparatively little attention in circadian biology. This review explores the bidirectional crosstalk between the methyl cycle and the mammalian circadian clock. We describe how S-adenosylmethionine-dependent epigenetic and epitranscriptomic modifications constitute essential layers of circadian gene regulation, and how the clock orchestrates the rhythmic expression of one-carbon metabolism enzymes and oscillations in S-adenosylmethionine availability. The direct interaction between the S-adenosylhomocysteine hydrolase AHCY and the core clock component BMAL1 at circadian gene promoters emerges as a molecular nexus linking methyl group supply to clock-driven transcription. We further discuss how the methyl cycle occupies a privileged position within the circadian entrainment hierarchy, acting as both a target of nutritional zeitgebers in peripheral tissues and a potential source of metabolic feedback to the central pacemaker, and how dietary perturbation of the methyl cycle disrupts circadian rhythms. Finally, we discuss how this crosstalk is implicated in metabolic liver disease, cancer, neurological disorders, and aging. Together, these findings position the circadian clock as a sensitive readout of nutritional methyl metabolic status, with broad implications for chronobiology and nutrigenomics.
    Keywords:  S-adenosylmethionine; circadian clock; epigenetics; epitranscriptomics; one-carbon metabolism
    DOI:  https://doi.org/10.1093/jb/mvag050
  35. bioRxiv. 2026 Jun 26. pii: 2026.06.22.732688. [Epub ahead of print]
      Iron deficiency anemia affects one-third of the global human population. Paradoxically, the daily iron required to fuel the production red blood cell (RBC) and prevent anemia is provided through its recycling from senescent RBC. This is achieved by splenic red pulp macrophages (RPM) that extract iron from the heme groups of hemoglobin (Hb). How these professional erythrophagocytic macrophages prevent intracellular iron flux from inducing cell death via ferroptosis is unknown. Here we show that SPI-C, the master transcriptional regulator of the erythrophagocytic lineage, orchestrates two redundant anti-ferroptosis pathways. One supports glutathione synthesis, via NF-E2-related factor 2 (NRF2), and the other relies on bilirubin production by biliverdin reductase A (BVRA). Genetic ablation of both pathways, but not either alone, sensitizes erythrophagocytic macrophages to ferroptosis, depletes RPM and increases the severity of iron deficiency anemia in mice. These findings reveal a central physiologic role of ferroptosis in the control of macrophage function, iron homeostasis and iron-deficiency anemia.
    Highlights: SPI-C enforces the antioxidant metabolic program of RPM.SPI-C controls bilirubin production by biliverdin reductase A.Bilirubin protects erythrophagocytic macrophages from ferroptosis.Ferroptosis protection supports iron-recycling macrophages and limit iron deficiency anemia.
    DOI:  https://doi.org/10.64898/2026.06.22.732688
  36. Elife. 2026 Jul 01. pii: e82205. [Epub ahead of print]15
      Eukaryotic mitochondria are characterized by several features that represent vestiges of their prokaryotic ancestry. One such feature is the N-terminal formylation of proteins encoded by mitochondrial DNA that undergo translation by mitochondrial ribosomes. N-formylated proteins are also released by bacteria and trigger activation of immune cells such as neutrophils. Growing evidence indicates that circulating levels of mitochondrial formyl proteins are elevated in the serum of patients with excessive inflammatory responses. However, the mechanisms by which they are released into circulation are not known. In this study, we have identified vascular endothelial cells as a source of Pink1-dependent release of mitochondrial formyl proteins in response to inflammatory mediators. Mechanistically, the mitophagy mediator Pink1 is stabilized by inflammatory activation of endothelial cells, promoting mitophagy and mitochondrial formyl peptide release both in mice and primary human endothelial cells. Using nanoparticle delivery of Pink1-targeting sgRNA in mice expressing endothelial-specific Cas9, we developed a mouse model in which Pink1 is specifically depleted in the endothelium. Deletion of endothelial Pink1 decreased circulating formyl peptide levels, lowered lung neutrophil infiltration and reduced mortality in mice. We thus propose that endothelial cells upregulate pro-inflammatory mitophagy in response to inflammation, leading to the release of mitochondrial formyl peptides and detrimental neutrophil recruitment into the lung.
    Keywords:  cell biology; human; immunology; inflammation; mouse
    DOI:  https://doi.org/10.7554/eLife.82205
  37. Nat Immunol. 2026 Jun 29.
      Acute myeloid leukemia (AML) is a blood cancer with poor survival outcomes. Acute respiratory failure frequently occurs due to leukemia infiltration of the lungs. Underlying mechanisms remain unexplored and therapeutic interventions remain empiric. Here we map the AML lung microenvironment at spatial and single-cell resolution. We show that extensive remodeling is coupled with inflammation and impaired tissue integrity and function. Steroid treatment significantly reduces AML burden and lung infiltration, improving oxygenation and pulmonary function. As a mechanistic correlate, the S-type lectin Lgals9 is triggered by inflammation and mediates cell-cell interactions within infiltrated lungs. Also, the alarmin IL-33 and its receptor (IL-1RL1) are involved in cell-cell interactions within the leukemic lung microenvironment. Targeting either the Lgals9 or IL-33 axis significantly decreases overall AML burden and lung infiltration through effects on both the immune microenvironment and AML cells. Our studies delineate pulmonary infiltration phenotypes in acute leukemia, enabling new treatment strategies.
    DOI:  https://doi.org/10.1038/s41590-026-02582-8
  38. Cell Metab. 2026 Jun 29. pii: S1550-4131(26)00230-5. [Epub ahead of print]
      Microbiome-derived metabolites, including short-chain fatty acids, bile acids, indoles, and lipopolysaccharides, among other bioactives, modulate mammalian immune cells through a variety of molecular processes, including epigenetic remodeling, mitochondrial metabolic reprogramming, and regulation of mTOR and AMPK signaling pathways. These diverse signals shape inflammatory programs that influence metabolic outcomes in a context-dependent manner, which may sustain metabolic health or drive chronic inflammation impacting obesity, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease, and cardiovascular diseases. Here, we review these metabolite-driven immune-metabolic influences and highlight innovative directions in their exploration, including integration of spatial and single-cell multi-omics to deconvolute microbiome-derived signaling networks within metabolic tissues. We further outline emerging microbiome-based therapeutic strategies targeting immune pathways in cardiometabolic disease, ranging from personalized nutrition, precision probiotics, and microbial consortium transplantation to metabolite-based postbiotics. Collectively, advancing our understanding of host immune-microbiome-metabolic interactions may support the development of targeted interventions for the prevention and treatment of cardiometabolic diseases.
    Keywords:  immune system; metabolism; metabolites; microbiome; microbiota; obesity
    DOI:  https://doi.org/10.1016/j.cmet.2026.06.004
  39. Sci Adv. 2026 Jul 03. 12(27): eaeb3363
      Affordable sequencing has flooded public databases with bacterial genomes; yet, species-scale maps that connect gene content variation to metabolic functions essential to biotechnology/system biology remain scarce. We address this gap by building a pangenome-wide gene-protein-reaction association and applying it to 2377 Escherichia coli genomes to reconstruct a pangenome-scale metabolic model (panGEM). We validate panGEM against Biolog carbon source utilization assays, achieving ≈0.99 precision in growth/no-growth predictions. Using panGEM, we identify >11,000 rare metabolic genes, yet only 35 metabolic reactions are rare. To explain the mismatch, we examined rare genes and found that most are pseudogenes or diverged orthologs acquired by horizontal gene transfer (HGT). Results indicate a recurrent loss-reacquisition cycle in which a core allele is lost/pseudogenized and its function is restored by HGT, preserving function without expanding the reactome, generating genetic heterogeneity in a small subset (~3.6%) of reactions, marking selection pressure hotspots of metabolism. Thus, pangenome annotation reveals the evolutionary dynamics that shape the genetic basis of metabolism.
    DOI:  https://doi.org/10.1126/sciadv.aeb3363
  40. Nat Genet. 2026 Jun 29.
      The theory of immunosurveillance posits that T cells eliminate clones harboring nonself-antigens generated by somatic mutations. Although a role of immunosurveillance in cancer is supported by evidence, whether it affects precancerous expansions has not been well established. Here we studied the association between MHC-variant binding and risk of clonal hematopoiesis (CH), a blood precancer state, predicting MHC binding affinity toward CH hotspot variants in 380,000 UK Biobank participants and examining the relationship between predicted binding to each variant and its expansion risk. Despite the study being powered to detect subtle differences in selective pressure, we did not find associations between predicted binding and CH prevalence for any of the examined variants. In CH-affected individuals, we identified no relationship between predicted variant binding and clone size. Overall, we found no evidence that the MHC genotype affects which variants expand in CH, suggesting a limited role for immunosurveillance in shaping clonal expansions in the blood.
    DOI:  https://doi.org/10.1038/s41588-026-02594-y
  41. Nat Commun. 2026 Jul 01.
      Transposable elements (TEs) are DNA sequences able to create copies of themselves within the genome. TEs have been shown to act as cis-regulatory elements and be co-opted in the human genome. Thus, their impact might come from their relationship with the epigenome. However, a systematic analysis that relates TEs with chromatin histone marks across human cell types remains lacking. Here we leverage a dataset from the International Human Epigenome Consortium featuring 4867 uniformly processed ChIP-seq experiments for 6 histone marks across 47 cell types and show that TEs have drastically different enrichments levels across histone marks. We find that TEs are generally depleted but enriched in select contexts such as L1s in H3K9me3 histone mark. Notably, we identify 456 cell type-histone-TE triplets with strong cell-type specific enrichments and show that many of these triplets are associated with relevant biological processes.
    DOI:  https://doi.org/10.1038/s41467-026-74920-1
  42. Autophagy. 2026 Jul 01.
      Macroautophagy/autophagy is an evolutionarily conserved degradation pathway wherein cytoplasmic components are sequestered within double-membrane autophagosomes for lysosomal delivery. The initiation of autophagy is governed by autophagy-related (ATG) proteins, with the ULK1 kinase complex serving as the most upstream regulator. However, how ULK1 senses and integrates metabolic signals via post-translational modifications remains poorly understood. Here, we discover that ULK1 undergoes lactylation at lysine 46, catalyzed by the mitochondrial aminoacyl-tRNA synthetase AARS2, in response to autophagic stimuli. This modification promotes ULK1 kinase activity, leading to enhanced and selective phosphorylation of its downstream substrate ATG14 at Ser29, thereby activating the class III PtdIns3K complex and facilitating autophagosome biogenesis. Furthermore, we demonstrate that AARS2-mediated ULK1 lactylation drives autophagic flux and promotes tumor metastasis in clear cell renal cell carcinoma (ccRCC), and that a cell-penetrating peptide targeting K46 lactylation suppresses ccRCC progression in vitro and in vivo. Our study identifies lactylation as a novel regulatory mechanism controlling autophagy initiation and suggests that targeting AARS2-mediated ULK1 lactylation could be a potential strategy for treating ccRCC.
    Keywords:  AARS2; ULK1; autophagy; clear cell renal cell carcinoma; lactylation; post-translational modification
    DOI:  https://doi.org/10.1080/15548627.2026.2694660
  43. Nat Commun. 2026 Jul 03. pii: 5844. [Epub ahead of print]17(1):
      In eukaryotes, meters of DNA are packaged into micrometer scale nuclei. Nucleosomes, as the major organizational unit, have been extensively studied in vitro, yet the elaborate 3D structure of chromatin inside cells and its distinct oligo-nucleosome arrangements remain poorly resolved. Here, we combine cryo-electron tomography with template matching, subtomogram averaging and molecular simulations to visualize nucleosomes and chromatin structure inside human cells. We confidently assign individual nucleosomes and report their in-situ structure at secondary structure resolution. By predicting the paths of linker DNA, we identify oligo-nucleosome arrangements and uncover higher-order chromatin structures in situ, including a 37-nm wide, elongated but non-fibrous arrangement. In situ structural biology thus reveals the molecular chromatin organization inside cells and sets the stage for 3D genomics.
    DOI:  https://doi.org/10.1038/s41467-026-75087-5
  44. Nat Aging. 2026 Jul 03.
      Exercise is fundamental to healthy aging, yet how it mitigates age-related molecular changes and how fitness level shapes exercise responses remain unclear. To address these questions, we performed transcriptomics, lipidomics and metabolomics on skeletal muscle of young and older adults with differing physical function, both before and after an acute bout of submaximal exercise. At baseline, older adults exhibited reduced expression of genes associated with cellular respiration and energy metabolism compared to young adults with comparable activity levels. Here we found that 50% of these age-related differences were absent in trained older adults, resulting in profiles resembling those of young adults. Although all participants displayed transcriptional immune and stress responses upon acute exercise, the magnitude of these responses in older adults was positively correlated with their physical fitness. Integrated multiomic analyses further revealed links among mitochondrial respiration, lipid metabolism, stress responses and NAD+ biology. These findings demonstrate that sustained physical training transforms age-related molecular profiles and provide a molecular atlas for study of fitness-dependent aging mechanisms.
    DOI:  https://doi.org/10.1038/s43587-026-01150-x
  45. medRxiv. 2026 Jun 24. pii: 2026.06.22.26356227. [Epub ahead of print]
      Mitochondrial DNA (mtDNA) heteroplasmy, the coexistence of multiple mtDNA variants within cells, accumulates with age and is associated with hematological malignancies and mortality. However, whether predicted deleterious heteroplasmies causally contribute to cancer or merely represent passenger mutations remains unresolved. Here, leveraging ∼36,000 first-degree relative pairs from the UK Biobank and All of Us Research Program cohorts, we deconvolute overall heteroplasmy metrics into those that are shared across family members (representing inherited variants) and those that are not (representing de novo variants) to establish a Mendelian randomization framework for assessing causality. We show that shared heteroplasmies exhibit strong purifying selection, with reduced predicted deleteriousness compared to not shared variants, and that 90% of an individual's deleterious heteroplasmy burden is somatically acquired. Critically, shared deleterious heteroplasmy burden, fixed at conception and thus temporally upstream of potential confounders, is significantly associated with hematological malignancies (RR=2.81, 95% CI 1.29-6.13), with effect sizes concordant with the not shared heteroplasmy burden. Furthermore, shared deleterious heteroplasmy specifically associates with high-risk clonal hematopoiesis of indeterminate potential (CHIP), particularly spliceosome mutations, suggesting mitochondrial dysfunction promotes clonal expansion of specific CHIP subtypes. Finally, we identify ultra-rare individual mtDNA variants associated with hematological malignancies, a hallmark of driver mutations. These findings establish mtDNA heteroplasmies, including inherited variants, as causal contributors to hematological malignancy risk and demonstrate that most disease-relevant burden is acquired during life, identifying potential opportunities for prevention and therapeutic intervention in individuals at elevated risk for hematological cancer, particularly of myeloid origin.
    DOI:  https://doi.org/10.64898/2026.06.22.26356227
  46. Cell Chem Biol. 2026 Jul 01. pii: S2451-9456(26)00155-8. [Epub ahead of print]
      Studies of regulated cell death have largely focused on the underlying mechanisms and modalities resulting in cell demise, as well as the biological and pathological consequences of cell death. More recently, at least some attention has turned to other questions: how do cells that engage a regulated cell death pathway sometimes survive? And do such "near-death experiences" alter the biology of the surviving cell? Like Alice passing through the looking glass, this 180° change in perspective may represent a paradigm shift in the field. Here, we discuss the concepts, mechanisms, and potential consequences of cell survival despite engaging a regulated cell death pathway.
    Keywords:  apoptosis; drug-tolerant persister cells; ferroptosis; necroptosis; pyroptosis
    DOI:  https://doi.org/10.1016/j.chembiol.2026.05.003
  47. NPJ Drug Discov. 2026 Feb 09. pii: 5. [Epub ahead of print]3(1):
      Clear cell renal cell carcinoma (ccRCC) is an aggressive malignancy with limited treatment options and high rates of resistance to first-line kinase inhibitors. Current therapies largely target the tumor microenvironment, leaving intrinsic tumor vulnerabilities underexplored. Here, we introduce a systems-based machine learning pipeline that integrates single-cell RNA sequencing, protein interaction networks, and drug proximity analysis to identify therapeutic targets in ccRCC. Candidate genes were refined using CRISPR screening data and functional relevance and validated across independent transcriptomic datasets. The pipeline recovered several established treatment pathways and uncovered previously underexplored therapeutic mechanisms, including ABL1, CDK4/6, and JAK inhibition. We identified FDA-approved compounds acting through these pathways, three of which, Ribociclib, Ponatinib, and Dasatinib, showed superior efficacy to current therapies across renal cancer cell lines in preclinical screens. By acting through mechanisms distinct from current therapies, they represent promising candidates for combination strategies aimed at overcoming resistance and improving clinical outcomes in ccRCC.
    DOI:  https://doi.org/10.1038/s44386-025-00036-z
  48. Immunity. 2026 Jun 30. pii: S1074-7613(26)00255-4. [Epub ahead of print]
      In cancer cells, pyruvate generated through aerobic glycolysis is preferentially converted into lactate. Here, we examined the impact of aerobic glycolysis on innate immune regulation within the tumor microenvironment. We identified lactate as a potent suppressor of stimulator of interferon genes (STING)-mediated innate immune signaling. Lactate directly bound the cyclic GMP-AMP (cGAMP)-binding domain of STING, thereby inhibiting cGAMP binding, STING activation, and interferon regulatory factor 3 (IRF3)-dependent cytokine expression. Mechanistically, activation of epidermal growth factor receptor (EGFR) promoted phosphorylation of lactate dehydrogenase A (LDHA) by pyruvate kinase M2 (PKM2) at serine 161 (S161). This increased LDHA activity and lactate production, which suppressed immune cell infiltration and promoted tumor growth. Pharmacological PKM2 inhibition relieved lactate-mediated STING suppression, reduced tumor immune evasion, and synergized with anti-PD-1 therapy. In human glioblastoma, elevated LDHA S161 phosphorylation correlated with reduced STING activation, diminished cytotoxic immune cell infiltration, and poor survival. Thus, oncogenic signaling directs PKM2-generated pyruvate toward LDHA-mediated lactate production, which directly inhibits STING to silence innate immune activation.
    Keywords:  EGFRvIII; LDHA; PD-1; PKM2; STING; immune evasion; lactate
    DOI:  https://doi.org/10.1016/j.immuni.2026.06.004
  49. Cell Death Dis. 2026 Jun 30.
      Acute myeloid leukemia (AML) exhibits metabolic reprogramming that supports immune evasion and treatment resistance. The kynurenine pathway (KP) is a key regulator of tumor-immune interactions, yet its downstream organization and clinical relevance in AML remain unclear. Here, we combined in vitro models with patient serum profiling to determine whether KP branching patterns are associated with treatment response. Extracellular KP metabolites were quantified in AML cell lines (HL-60 and MOLM-14) following induction regimens, and quantified circulating KP metabolites in patient serum samples collected from AML patients before and after induction therapy. Treatment was associated with normalization of tryptophan depletion and kynurenine accumulation in responders, indicating partial restoration of systemic KP homeostasis. Notably, baseline (pre-treatment) samples from patients who were later classified as non-responders exhibited a distinct metabolic phenotype characterized by persistent kynurenine elevation, increased anthranilic and kynurenic acid levels, and enrichment of 3-hydroxykynurenine flux, suggesting preferential engagement of oxidative and immunomodulatory KP branches. Among evaluated metabolic indices, the 3-hydroxykynurenine-to-kynurenine ratio demonstrated the strongest discriminatory capacity for distinguishing response to induction therapy (DA: daunorubicin + cytarabine; DAC: daunorubicin + cytarabine + cladribine), outperforming individual metabolite measurements and highlighting functional pathway flux rather than absolute metabolite abundance as a determinant of clinical outcome.
    DOI:  https://doi.org/10.1038/s41419-026-09050-z
  50. Nat Commun. 2026 Jun 27.
      Ferritin, composed of heavy chain (FTH1) and light chain (FTL) subunits, is a key intracellular iron storage protein, but the origin and biological role of extracellular ferritin (ex-ferritin) remain poorly understood. Elevated serum ex-ferritin is associated with worse outcomes in acute respiratory distress syndrome (ARDS). Here, we show that both FTH1 and FTL are significantly enriched in the serum, blood monocytes, and alveolar macrophages (AM) of individuals with ARDS, findings we replicate in a murine hyperoxia-induced acute lung injury model. Myeloid-specific FTH1 (Fth1ΔLysM) deletion attenuates lung injury, and is associated with reduced macrophage ferroptosis, altered airway inflammatory responses, lower extracellular iron and compensatory secretion of FTL-ex-ferritin. While pharmacologic ferroptosis inhibition prior to hyperoxia had no effect, transplantation of FTL-ex-ferritin-enriched bronchoalveolar lavage fluid conferred protection from lung injury. These findings identify macrophage ferritin metabolism and ex-ferritin secretion as critical regulators of lung injury, offering new insights into the pathobiology of ARDS.
    DOI:  https://doi.org/10.1038/s41467-026-74828-w
  51. Cell. 2026 Jun 30. pii: S0092-8674(26)00696-3. [Epub ahead of print]
      Tissue regeneration requires de novo patterning, which has been proposed to be facilitated by cellular heterogeneity. Yet how such heterogeneities are integrated with the mechanochemical state of the tissue and stabilized at the chromatin level into stable, spatially organized fates remains poorly understood. Using in vivo mouse intestinal regeneration models and organoids, we identify a critical density regime that produces a permissive window for heterogeneity in the mechanosensor Yes-associated protein 1 (YAP1). We show that YAP1 heterogeneity is coupled to lineage-biased chromatin accessibility and is decoded through FOXA1, which integrates the permissive chromatin state to Delta-Notch supracellular feedback and lineage commitment. This circuit generates fate bistability and preserves a memory of transient YAP1 activity, thereby maintaining spatial patterning as tissues return to homeostasis after injury. Together, our findings establish a multiscale framework in which tissue-scale mechanics tune single-cell competence and, through FOXA1-mediated bistability, convert transient heterogeneity into stable and self-organized tissue architecture.
    Keywords:  Yap1; epigenetic competence; heterogeneity; image-based phenotyping; intestinal regeneration; mechanics; modeling; multiscale integration; organoids; tissue patterning
    DOI:  https://doi.org/10.1016/j.cell.2026.06.009